Phase 3 — Phytochemical Screening & Characterization

Phase 3 — Phytochemical Screening & Characterization contains 7 topic pages in Phytopharmacy & Phytomedicine.

Preliminary phytochemical screening employs simple, rapid colour and precipitation reactions to identify the major classes of secondary metabolites present in a crude plant extract, guiding subsequent isolation priorities before committing to the far more resource-intensive process of full chromatographic and spectroscopic characterisation. Alkaloids are detected using Dragendorff's reagent (potassium bismuth iodide), which produces an orange-red precipitate, or the complementary Mayer's and Wagner's reagents, which yield cream and brown precipitates respectively, tested in an acidified aqueous extract. Flavonoids are detected by the Shinoda test, in which magnesium turnings combined with concentrated hydrochloric acid produce a pink-to-magenta colouration in a positive sample. Tannins are detected using ferric chloride solution, which produces a blue-black colouration with hydrolysable tannins and a green-black colouration with condensed tannins. Saponins are detected by a simple foam test, in which vigorous shaking of the aqueous extract produces a persistent froth lasting at least fifteen minutes, reflecting their inherent surfactant properties. Terpenoids and steroids are distinguished using the Salkowski test and the closely related Liebermann–Burchard test, in which a reddish-brown interface indicates terpenoids while a green or blue colouration indicates steroidal structures. Glycosides are detected by the Keller–Kiliani test, which produces a reddish-brown ring at the interface in the presence of a deoxy sugar characteristic of cardiac glycosides, while anthraquinones are detected by Borntrager's test, in which alkaline extraction produces a rose-pink to red colouration. Phenolic compounds are detected using neutral ferric chloride or, for quantitative purposes, the Folin–Ciocalteu reagent, which produces a blue colouration proportional to total phenolic content. Secondary metabolites are plant-derived compounds that, unlike primary metabolites such as carbohydrates, proteins, and lipids, are not directly required for basic cellular metabolism but instead serve ecological functions such as defence against herbivory and pathogens, and it is this same chemical reactivity and biological specificity that renders them pharmacologically valuable to humans. Alkaloids, nitrogen-containing basic compounds biosynthesised principally from amino acid precursors, include the analgesic morphine, the antimalarial quinine, and the anticancer vinca alkaloids, and are conventionally sub-classified by their nitrogen-containing ring system (indole, isoquinoline, tropane, and pyrrolizidine alkaloids, among others). Flavonoids, a large family of polyphenolic compounds built on a C6-C3-C6 carbon skeleton and biosynthesised via the phenylpropanoid pathway, include flavones, flavonols, flavanones, isoflavones, and anthocyanins, and are broadly associated with antioxidant, anti-inflammatory, and vascular-protective activity. Terpenoids, derived biosynthetically from the isoprene (C5) unit through the mevalonate or non-mevalonate (MEP) pathway, are classified by the number of isoprene units incorporated into monoterpenes, sesquiterpenes, diterpenes, triterpenes, and higher polymeric forms, and encompass compounds ranging from menthol to the anticancer diterpenoid paclitaxel. Glycosides consist of a non-sugar aglycone linked to one or more sugar units via a glycosidic bond, a linkage that markedly influences the compound's water solubility, absorption, and biological potency relative to the free aglycone; cardiac glycosides, anthraquinone glycosides, and cyanogenic glycosides represent pharmacologically important sub-classes. Tannins, high-molecular-weight polyphenolic compounds capable of precipitating proteins, are divided into hydrolysable tannins (esters of gallic or ellagic acid with a sugar core) and condensed tannins (oligomeric or polymeric flavan-3-ol units), and underlie the traditional astringent and wound-healing use of numerous medicinal plants. Saponins, glycosides bearing a triterpenoid or steroidal aglycone, are characterised by their surfactant, foam-forming property and are of pharmacological interest for adjuvant, haemolytic, and cholesterol-lowering activity. Once a phytoconstituent has been isolated in pure form, its complete chemical structure must be elucidated using a complementary suite of spectroscopic techniques, each contributing distinct structural information that, combined, allows unambiguous structure determination even for entirely novel natural products.

Ultraviolet-Visible (UV-Vis) Spectroscopy

UV-Vis spectroscopy reveals the wavelength of maximum absorption (λmax), which is diagnostic of the compound's chromophoric system; for flavonoids in particular, the characteristic bathochromic (red) shift in λmax observed upon addition of shift reagents such as sodium hydroxide or aluminium chloride provides direct information about the pattern and position of hydroxyl substitution on the flavonoid skeleton.

Fourier-Transform Infrared (FTIR) Spectroscopy

FTIR spectroscopy identifies the functional groups present in a molecule by their characteristic vibrational absorption frequencies across the 4000–400 cm⁻¹ range, including broad O–H stretching around 3200–3550 cm⁻¹, carbonyl (C=O) stretching around 1700–1750 cm⁻¹, aromatic C=C stretching around 1450–1600 cm⁻¹, and C–O–C ether stretching around 1000–1300 cm⁻¹, providing a rapid functional-group fingerprint that complements the more detailed structural information obtained from NMR.

Nuclear Magnetic Resonance (NMR) Spectroscopy

Proton (¹H) NMR, typically recorded at 400 or 600 MHz, reveals the chemical environment of each hydrogen atom through its characteristic chemical shift, coupling pattern, and coupling constant, providing detailed information about the connectivity and stereochemistry of the molecule; carbon (¹³C) NMR and the DEPT (Distortionless Enhancement by Polarisation Transfer) experiment together establish the complete carbon framework, distinguishing methyl, methylene, methine, and quaternary carbons. Two-dimensional NMR experiments provide the definitive structural evidence required for novel compound elucidation: COSY reveals proton-proton coupling networks, HSQC reveals direct one-bond carbon-hydrogen correlations, and HMBC reveals longer-range two- to three-bond carbon-hydrogen correlations that allow entire ring systems and substituent attachment points to be established unambiguously.

Mass Spectrometry (MS)

High-resolution mass spectrometry, commonly using electrospray ionisation coupled to a quadrupole time-of-flight (ESI-QTOF) analyser, establishes the exact molecular mass and, from it, the molecular formula of a compound with high confidence, while the fragmentation pattern observed provides further structural clues; characteristic neutral losses, such as 162 Da for a glucose unit or 146 Da for a rhamnose unit, are particularly diagnostic for glycosidic natural products and allow the sugar substitution pattern to be inferred directly from the mass spectrum. Marker compound analysis integrates the chromatographic and spectroscopic techniques described above into a coherent characterisation strategy for a herbal drug or extract, in which one or more chemically defined, quantifiable constituents are designated as the analytical marker against which identity and quality are routinely assessed. A marker compound may be an 'active marker', directly responsible for the observed pharmacological activity, or an 'analytical marker', selected purely for its reliable presence and ease of quantification even where it is not itself the principal active constituent; both types serve the essential quality-control function of providing an objective, reproducible chemical benchmark for a botanically and phytochemically variable starting material. Comprehensive herbal drug characterisation combines qualitative identity confirmation (by TLC/HPTLC fingerprint matching), quantitative marker assay (by validated HPLC), and, where a novel or poorly characterised constituent is involved, full structure elucidation by the NMR and mass spectrometric methods described above. Dereplication is the strategic process of rapidly identifying already-known compounds within a crude extract at an early stage, so that isolation effort can be concentrated on genuinely novel structures rather than repeatedly re-isolating previously characterised natural products. The standard dereplication workflow couples liquid chromatography with photodiode-array and mass spectrometric detection (LC-PDA-MS) to obtain a UV absorption spectrum and accurate molecular mass for every peak in the crude extract, which are then cross-referenced against natural product databases such as the Dictionary of Natural Products, SciFinder, or the Global Natural Products Social Molecular Networking (GNPS) platform; only peaks lacking a confident database match, or peaks associated with strong and reproducible biological activity, are prioritised for full isolation. Bioassay-guided fractionation applies the complementary principle that isolation effort should be directed by demonstrated biological activity rather than by abundance alone: the crude extract is first confirmed active in the relevant assay (for example enzyme inhibition, antimicrobial, or cytotoxicity screening), sequentially fractionated by polarity-graded column chromatography, with every resulting fraction re-tested for activity, and the most active fraction is then sub-fractionated further through successive rounds of chromatography until a single pure, biologically active compound is obtained and its structure determined. This strategy ensures that the isolated compound is genuinely responsible for the observed activity, rather than being isolated merely on the assumption that it belongs to a pharmacologically promising chemical class. Phase 3 has described the full analytical pathway from crude extract to fully characterised phytoconstituent: preliminary colour-reaction screening for rapid class identification, the major biosynthetic classes of secondary metabolites, chromatographic fingerprinting and quantification by TLC, HPTLC, and HPLC, structure elucidation by UV, FTIR, NMR, and mass spectrometry, and the strategic use of dereplication and bioassay-guided fractionation to prioritise isolation effort. This analytical foundation, and specifically the marker compounds identified and quantified in this phase, underpins both the biological activity evaluation of Phase 4 and the formal standardisation requirements of Phase 5.